Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Free Cash Flow Growth (1y) (2018 - 2026)

Analysis

Catheter Precision (VTAK) Free Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 28.87%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 69.33%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 120.89%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 14.12%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 13.29%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 142.84%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -0.16%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -11.68%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -14.34%
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 -28.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -28.41%
Mar 31, 2026 -19.51%
Dec 31, 2025 47.63%
Sep 30, 2025 20.56%
Jun 30, 2025 -30.31%
Mar 31, 2025 -19.55%
Dec 31, 2024 -50.18%
Sep 30, 2024 -51.17%
Jun 30, 2024 64.21%
Mar 31, 2024 83.76%
Dec 31, 2023 37.31%
Sep 30, 2023 63.13%
Jun 30, 2023 18.99%
Mar 31, 2023 -41.09%
Dec 31, 2022 47.11%
Sep 30, 2022 32.25%
Jun 30, 2022 10.46%
Mar 31, 2022 -5.82%
Dec 31, 2021 38.87%
Sep 30, 2021 -20.76%